The
anticancer agent saintopin induces DNA cleavage mediated by both topoisomerase (
topo) I and
topo II in vitro through stabilization of the reversible
enzyme-
DNA cleavable complex. We established
saintopin-resistant cell lines (KB/STP-1 and KB/STP-2) from human epidermoid
cancer KB cells by stepwise exposure to increasing doses of the
drug. KB/STP-1 and KB/STP-2 cells showed 12- and 44-fold increases, respectively, in resistance to
saintopin relative to that of KB cells. Both
saintopin-resistant cell lines showed only small reductions in sensitivity to the
topo II inhibitor
etoposide but developed marked cross-resistance to the
topo I-targeting
camptothecin derivative
CPT-11 [(4s)-4,11-diethyl-4-hydroxy-9-[(4-piperidinopiperidino)carbony loxy] dione hydrochloride trihydrate] and its active form,
SN-38 (7-ethyl-10-hydroxycamptothecin). In contrast, both KB/STP-1 and KB/STP-2 cells showed increased collateral sensitivity to
cisplatin, a nitrosourea derivative,
mitomycin C, and UV light. The
protein concentration, activity, and
mRNA abundance of both
topo I and
topo II were similar in KB/STP-1, KB/STP-2, and the parental KB cells. There were no significant changes in the
drug-stabilized
topo-
DNA cleavable complex formation in KB and KB/STP-2 cells. Two point mutations were detected in
topo I
cDNA from KB/STP-2 cells, but these were also present in KB cells.
Topo I
mRNA abundance decreased markedly immediately after exposure of KB/STP-2 cells to
saintopin; no such effects were apparent in KB cells. In contrast,
topo II
mRNA was not markedly affected by
saintopin in either KB or KB/STP-2 cells. Treatment with
CPT-11 or
SN-38 also induced a markedly greater and more persistent reduction in
topo I
mRNA abundance in KB/STP-2 cells than in KB cells.
Etoposide had no marked effect on
topo I
mRNA abundance in either KB/STP-2 or KB cells.
Topo I
mRNA was highly unstable in KB/STP-2 cells in comparison to KB cells when incubated with
saintopin. This novel regulation of
topo I
mRNA by
topo I-targeting agents could be associated with acquirement of drug resistance to
saintopin or
SN-38/
CPT-11 in KB/STP-2 cells.